RetroSense Therapeutics’ Clinical-Stage Development Program to Restore Vision Wins Multiple Awards
ANN ARBOR, Mich.--(BUSINESS WIRE)--Therapeutic Area Partnerships has selected RetroSense lead compound, RST-001, as a “Top Project to Watch: Most Licensable Products" and also won the “Deals of the Year” Research Award.
